The genetic variation of BChE deficiency was described by Kalow and Genest in 1957 and is said to be a cornerstone in pharmacogenetics/pharmacogenomics [4]. The gene discussed is BCHE; the disease is hyperinsulinemic hypoglycemia, familial, 4.